UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Derjung Tarn, MD, PhD

Print
Email

Derjung Mimi Tarn, MD, PhD

UCLA Physician Derjung Mimi  Tarn, MD, PhD specializes in Family Practice Medicine.
This primary care physician is accepting new managed care (HMO) patients. Physician availability is subject to change. Please call the physician's office directly to confirm
Specialty
Family Practice Medicine
Gender
Female
Language Spoken
English
Hospital Affiliation
UCLA Medical Center, Santa Monica
State License Number
A72710
Contact
(310) 319-4700 Information and referral
PRACTICE LOCATION

UCLA Family Health Center
1920 Colorado Avenue
Santa Monica, CA 90404-3414
(310)319-4700
(310)453-5106 (fax)

MEDICAL BOARD CERTIFICATION
Family Medicine, American Board of Family Medicine, 2002, 2009
EDUCATION
Fellowship
Family Practice, UCLA School of Medicine, 2005 - 2006
Family Practice, Primary Care Research, UCLA School of Medicine, 2002 - 2005
Residency
Family Practice, Presbyterian Intercommunity Hospital, 2000 - 2002
Internship
Family Practice, Presbyterian Intercommunity Hospital, 1999 - 2000
Degree
MD, New York Medical College, 1999
MORE INFORMATION
Research Interest
Physician-patient communication, prescription medications, mixed methods research, qualitative research
Awards & Recognition
  • 2010 California Academy of Family Physicians Researcher of the Year
  • 2009 Fellow, NIH OBSSR Summer Institute on the Design and Conduct of Randomized Clinical Trials Involving Behavioral Interventions
  • 2008 Society of Teachers in Family Medicine Best Paper Award Honorable Mention
Publications
  1. Tarn DM and Flocke SA. New Prescriptions: How Well Do Patients Remember Important Information? Fam Med. 2011; 43: 254-9.
  2. Frosch DL, Grande D, Tarn DM, Kravitz RL. A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. Am J Public Health. 2010; 100: 24-32.
  3. Tarn DM, Paterniti DA, Kravitz RL, Fein S, Wenger NS. How do physicians conduct medication reviews? J Gen Int Med 2009; 24: 1296-302.
  4. Moreno G, Tarn DM, Morales LS. Impact of interpreters on the receipt of new prescription medication information among Spanish-speaking Latinos. Medical Care 2009; 47: 1201-208.
  5. Tarn DM, Paterniti DA, Williams BR, Cipri CS, Wenger NS. Which Providers Should Communicate Which Critical Information About a New Medication? Patient, Pharmacist, and Physician Perspectives. J Am Geriatr Soc 2009; 57: 462-69.
  6. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Prescribing New Medications: A Taxonomy of Physician-Patient Communication. Communication and Medicine. 2008; 5(2): 195-208.
  7. Tarn DM, Paterniti DA, Kravitz RL, Heritage J, Liu H, Kim S, Wenger NS. How much time does it take to prescribe a new medication? Pat Educ and Couns. 2008; 72: 311-19.
  8. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician Communication about the Cost and Acquisition of Newly Prescribed Medications. Am J Manag Care. 2006; 12:657-64.
  9. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician Communication when Prescribing New Medications. Arch Intern Med. 2006; 166:1855-62.
  10. Tarn DM, Meredith LS, Kagawa-Singer M, Matsumura S, Bito S, Oye RK, Liu H, Kahn KL, Wenger NS. Patients’ Trust in Their Physicians: The Role of Ethnic Match, Autonomy, Acculturation, and Religiosity. Ann Fam Med. 2005; 3:339-47.
  11. Terris DJ, Cheng EC, Utley DS, Tarn DM, Ho PR, Verity AN. Functional recovery following nerve injury and repair by silicon tubulization: comparison of laminin-fibronectin, dialyzed plasma, collagen gel, and phosphate buffered solution. Auris Nasus Larynx. 1999; 26:117–22.
  12. Ho PR, Coan GM, Cheng ET, Niell C, Tarn DM, Zhou H, Sierra DH, Terris DJ. Repair with collagen tubules linked with BDNF and CNTF in a rat sciatic nerve injury model. Arch Otolaryngol Head Neck Surg. 1998; 124:761–66.
  13. Cheng ET, Utley DS, Ho PR, Tarn DM, Coan GM, Verity AN, Sierra DH, Terris DJ. Functional recovery of transected nerves treated with systemic BDNF and CNTF. Microsurgery. 1998; 18:35–41.
  14. Tarn DM and Marmor MF. Modulation and mechanisms of electroretinogram recovery after short-term retinal ischemic injury. Documenta Ophthalmologica. 1996; 91:109–16.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Derjung Tarn, click here to update your profile.